Trial intelligence / Profile preview

Ketamine in Sleeve Gastrectomy

IRCT20240424061560N1Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketamine in class III obesity, sponsored by Baqiyatallah University of Medical Sciences. Started Dec 2024; status: completed.

02

Drugs

ketamine
03

Conditions

class III obesity

Beyond the preview

Go deeper on IRCT20240424061560N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240424061560N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call